vTv Therapeutics VTVT
€ 12.95
6.0%
Quartalsbericht 2023-Q2
hinzugefügt 11.08.2023
vTv Therapeutics Kennzahlen 2011-2024 | VTVT
Kennzahlen Jährlich vTv Therapeutics
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
- | - | - | -5.2 | -4.3 | -4.6 | -3.3 | -2.2 | - | - | - | - |
P/S |
- | - | - | 24.4 | 2.8 | 257.8 | 84.9 | 115.6 | - | - | - | - |
EPS |
- | - | - | - | - | - | - | - | - | - | - | - |
EV (Enterprise Value) |
15.3 M | -3.16 M | 5.25 M | 124 M | 124 M | 242 M | 148 M | 142 M | 510 M | 318 M | - | - |
EBITDA per Share |
- | - | - | -0.688 | -1.57 | -5.21 | -5.74 | -4.55 | - | - | - | - |
EV/EBITDA |
0.1 | -7298.0 | -3.5 | -2.5 | -1.6 | -0.2 | 0.7 | - | - | - | - | |
PEG |
- | -76.9 | -0.36 | -0.07 | -1.99 | -0.07 | 0.01 | - | - | - | - | |
P/B |
- | - | - | -1.4 | -0.4 | -0.5 | -0.6 | -0.8 | - | - | - | - |
P/CF |
- | - | - | -2.9 | -1.3 | -1.7 | -1.1 | -1.6 | - | - | - | - |
ROE % |
178.44 | 133.34 | 10.61 | 26.61 | 9.55 | 10.69 | 17.98 | 35.27 | - | - | - | - |
ROA % |
-57.66 | -50.98 | -57.47 | -140.77 | -92.43 | -57.83 | -30.01 | -30.04 | - | - | - | - |
ROCE % |
209.87 | 222.40 | 14.80 | 507.70 | 192.88 | -5129.76 | -127.77 | -45.51 | - | - | - | - |
Current Ratio |
1.2 | 2.5 | 1.3 | 0.2 | 0.2 | 0.8 | 4.6 | 11.5 | - | - | - | - |
DSO |
20.8 | 9.8 | 4.6 | 0.7 | - | 10034.4 | - | 48.5 | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - |
Betriebszyklus |
20.8 | 9.8 | 4.6 | - | - | - | - | - | - | - | - | - |
Finanzkreislauf |
20.8 | 9.8 | 4.6 | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Kennzahlen Vierteljährlich vTv Therapeutics
2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
97.10 | 111.83 | 149.26 | 154.30 | 133.63 | 97.94 | 13.85 | 15.77 | 12.64 | 15.57 | 12.02 | 20.99 | 26.44 | 28.11 | 26.61 | 18.95 | 12.55 | 10.38 | 9.55 | 11.09 | 12.54 | 11.46 | 10.69 | 12.29 | 14.26 | 16.54 | 17.98 | 17.59 | 18.46 | 26.92 | 35.27 | 32.75 | 28.66 | 15.31 | 2.72 | 1.18 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-64.66 | -48.12 | -55.23 | -58.69 | -50.15 | -44.44 | -31.58 | -41.94 | -48.85 | -68.82 | -65.08 | -112.56 | -141.13 | -149.46 | -140.77 | -106.04 | -76.41 | -81.20 | -92.43 | -95.12 | -98.90 | -77.20 | -57.83 | -49.82 | -44.07 | -38.05 | -30.01 | -26.04 | -23.19 | -26.39 | -30.04 | -86.15 | -126.99 | -115.62 | -104.90 | -45.32 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
139.01 | 154.60 | 161.65 | 169.09 | 142.19 | 104.73 | 24.81 | 28.35 | 24.44 | 19.92 | 17.08 | 30.11 | 37.64 | 42.17 | 42.62 | 30.01 | 20.73 | 21.65 | 23.93 | 31.96 | 37.81 | 35.47 | 33.55 | 39.74 | 46.97 | 54.72 | 60.50 | 60.08 | 57.32 | 51.34 | 48.92 | 36.03 | 25.03 | 14.91 | 2.44 | 1.11 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
0.8 | 1.0 | 1.2 | 1.3 | 1.2 | 1.4 | 2.5 | 3.8 | 2.3 | 1.6 | 1.3 | 1.3 | 1.3 | 1.3 | 0.5 | 0.5 | 0.5 | 0.5 | 0.3 | 0.3 | 0.3 | 0.3 | 0.6 | 0.6 | 0.6 | 0.6 | 2.4 | 2.4 | 2.4 | 2.4 | 11.5 | 11.5 | 11.5 | 11.5 | 0.2 | 0.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | 679.3 | 2.6 | - | 14.1 | 10.1 | 7.4 | - | 2059.6 | 1802.2 | 929.6 | 65.2 | 57.0 | 0.2 | 0.2 | - | 30.7 | 45.8 | 181.5 | 3133.1 | 48666.7 | 56153.8 | 12166.7 | - | - | - | 8.4 | 27.9 | 47.3 | 57.2 | 63.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebszyklus |
- | - | - | - | 679.3 | 2.6 | - | 14.1 | 10.1 | 7.4 | - | 2059.6 | 1802.2 | 929.6 | 65.2 | 57.0 | 0.2 | 0.2 | - | 30.7 | 45.8 | 181.5 | 3133.1 | 48666.7 | 56153.8 | 12166.7 | - | - | - | 8.4 | 27.9 | 47.3 | 57.2 | 63.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Finanzkreislauf |
- | - | - | - | 679.3 | 2.6 | - | 14.1 | 10.1 | 7.4 | - | 2059.6 | 1802.2 | 929.6 | 65.2 | 57.0 | 0.2 | 0.2 | - | 30.7 | 45.8 | 181.5 | 3133.1 | 48666.7 | 56153.8 | 12166.7 | - | - | - | 8.4 | 27.9 | 47.3 | 57.2 | 63.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung